NEW YORK (GenomeWeb News) – AnaSpec today said that it has signed a non-exclusive agreement that will allow Yope Biotechnology to distribute its catalog and custom products in China.
 
The agreement is AnaSpec’s second distribution deal for China in as many months. In November, the company announced a similar non-exclusive agreement with Shanghai Universal.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.